- 专利标题: ANTI-CD73 ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF
-
申请号: US18253703申请日: 2021-11-19
-
公开(公告)号: US20240002527A1公开(公告)日: 2024-01-04
- 发明人: Bing XIA , Cui FENG , Lixia GU , Chen LI , Yuhong ZHOU , Ziping WEI
- 申请人: BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD.
- 申请人地址: CN Hangzhou, Zhejiang
- 专利权人: BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD.
- 当前专利权人: BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD.
- 当前专利权人地址: CN Hangzhou, Zhejiang
- 国际申请: PCT/CN2021/131791 2021.11.19
- 进入国家日期: 2023-05-19
- 主分类号: C07K16/28
- IPC分类号: C07K16/28 ; A61K47/68 ; A61P35/00
摘要:
Isolated anti-human CD73 antibody includes two heavy chains each including a hinge region comprising an amino acid sequence of that allow site-specific conjugation of cytotoxic drugs. Each heavy chain can include a human CH1 domain located upstream of and connected to the hinge region. The CH1 domain comprising a cysteine at the position of 142 according to the IMGT numbering scheme. ADCs containing the antibody conjugated with a cytotoxic drug are also provided. Pharmaceutical compositions including the antibody or the ADCs, and methods of treating cancer using the pharmaceutical compositions are also provided.
信息查询